|
Market Closed -
Xetra
18:35:10 27/08/2026 +03
|
After hours 22:59:58 | |||
| 48.48 EUR | -1.28% |
|
48.44 | -0.07% |
| 08-25 | Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer | CI |
| 08-24 | CAC 40 pauses ahead of Nvidia and Jackson Hole |  |
Published on 02/06/2026 at 06:35 pm +03 - Modified on 03/24/2026 at 01:35 am +03
Presenter Speech
Alexander Siedler (Executives)
Hello. Good morning and good afternoon, everybody, and welcome to our investor webinar on the results of the OCEANIC-STROKE Phase III trial directly live
A
Select your edition
All financial news and data tailored to specific country editions
